» Articles » PMID: 17006913

Glutamine: a Trojan Horse in Ammonia Neurotoxicity

Overview
Journal Hepatology
Specialty Gastroenterology
Date 2006 Sep 29
PMID 17006913
Citations 159
Authors
Affiliations
Soon will be listed here.
Abstract

Mechanisms involved in hepatic encephalopathy still remain to be defined. Nonetheless, it is well recognized that ammonia is a major factor in its pathogenesis, and that the astrocyte represents a major target of its CNS toxicity. In vivo and in vitro studies have shown that ammonia evokes oxidative/nitrosative stress, mitochondrial abnormalities (the mitochondrial permeability transition, MPT) and astrocyte swelling, a major component of the brain edema associated with fulminant hepatic failure. How ammonia brings about these changes in astrocytes is not well understood. It has long been accepted that the conversion of glutamate to glutamine, catalyzed by glutamine synthetase, a cytoplasmic enzyme largely localized to astrocytes in brain, represented the principal means of cerebral ammonia detoxification. Yet, the "benign" aspect of glutamine synthesis has been questioned. This article highlights evidence that, at elevated levels, glutamine is indeed a noxious agent. We also propose a mechanism by which glutamine executes its toxic effects in astrocytes, the "Trojan horse" hypothesis. Much of the newly synthesized glutamine is subsequently metabolized in mitochondria by phosphate-activated glutaminase, yielding glutamate and ammonia. In this manner, glutamine (the Trojan horse) is transported in excess from the cytoplasm to mitochondria serving as a carrier of ammonia. We propose that it is the glutamine-derived ammonia within mitochondria that interferes with mitochondrial function giving rise to excessive production of free radicals and induction of the MPT, two phenomena known to bring about astrocyte dysfunction, including cell swelling. Future therapeutic approaches might include controlling excessive transport of newly synthesized glutamine to mitochondria and its subsequent hydrolysis.

Citing Articles

The Glutamate/GABA-Glutamine Cycle: Insights, Updates, and Advances.

Andersen J J Neurochem. 2025; 169(3):e70029.

PMID: 40066661 PMC: 11894596. DOI: 10.1111/jnc.70029.


Oral Administration of L-Arginine Improves the Growth and Survival of Sow-Reared Intrauterine Growth-Restricted Piglets.

Long D, Long B, Nawaratna G, Wu G Animals (Basel). 2025; 15(4).

PMID: 40003032 PMC: 11851912. DOI: 10.3390/ani15040550.


The Balance of Ketoacids α-Ketoglutarate and α-Ketoglutaramate Reflects the Degree of the Development of Hepatoencephalopathy in Rats.

Shurubor Y, Keskinov A, Yudin V, Krasnikov B Int J Mol Sci. 2025; 25(24.

PMID: 39769330 PMC: 11677448. DOI: 10.3390/ijms252413568.


Hepatic encephalopathy as a result of ammonia-induced increase in GABAergic tone with secondary reduced brain energy metabolism.

Sorensen M, Andersen J, Bjerring P, Vilstrup H Metab Brain Dis. 2024; 40(1):19.

PMID: 39560844 PMC: 11576828. DOI: 10.1007/s11011-024-01473-x.


Bibliometrics and knowledge mapping of the pathogenesis of hepatic encephalopathy in patients with liver cirrhosis.

Wu S, Li L, Xi H, Wu X, He Y, Sun X Heliyon. 2024; 10(15):e34330.

PMID: 39145014 PMC: 11320160. DOI: 10.1016/j.heliyon.2024.e34330.